QualityStocksNewsBreaks Archives - Page 833 of 1454

MondayDec 28, 2020 2:38 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) Pairs Sales, Outreach with Expansive Broker Networks for Dynamic Growth

InsuraGuest Technologies (TSXV: ISGI), via its wholly-owned subsidiary InsuraGuest Inc., recently signed an Agent Producer Agreement with USI Insurance Services (“USI”), a leading U.S.-based insurance brokerage and consulting firm. Under the agreement, USI will distribute InsuraGuest’s innovative Hospitality Liability coverages through its nationwide network of more than 7,500 professional brokers. A recent article discussing this reads, “This agreement with USI continues a series of partnerships that InsuraGuest has been signing lately to expand the reach of its insurtech platform and insurance services. ‘InsuraGuest continues to attract and execute exciting relationships with nationally recognized leaders in the insurance industry,’ CEO and…

MondayDec 28, 2020 2:20 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) on Track to Leverage Psychedelics to Target Depression

Cybin (NEO: CYBN), a mushroom life science company, is set to leverage opportunity amid growing research that demonstrates the significant role psilocybin could play in alleviating symptoms of major depression. According to a recent study conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry,” only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in symptoms in adults with major depression (https://ibn.fm/ZpmzM). “The magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market,” stated Alan Davis, PhD., adjunct assistant professor of psychiatry and…

MondayDec 28, 2020 2:00 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Positioned Amid Surging Demand in EV Space

Net Element (NASDAQ: NETE), a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc., is poised as the EV sector has seen a sharp uptick in consumer demand and investor interest. Rising demand is driven by a combination of improved sector fundamentals coupled with positive industry news. A recent article discussing the company reads, “A potential combined Net Element-Mullen Technologies entity plans to leverage upon the surge in consumer demand within the electric vehicle space through the launch of its initial…

MondayDec 28, 2020 11:09 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers CNS Pharmaceuticals’ Investigational New Drug (“IND”) application for its lead product candidate, Berubicin, for the treatment of Glioblastoma Multiforme (“GBM”). The IND is now approved and in effect as filed with the U.S. Food and Drug…

MondayDec 28, 2020 10:33 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Pricing of $26M Registered Direct Offering

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has announced its entry into definitive agreements with investors for the purchase and sale of 6,265,063 of Foresight’s American Depositary Shares (“ADSs”), each at a price of $4.15, per a registered direct offering. The company will secure approximately $26 million in gross proceeds before deducting placement agent fees and other estimated offering expenses. Foresight intends to use the net proceeds for working capital and other general corporate purposes. The closing of the registered direct offering is expected to take place on or about Dec. 30, 2020, subject…

MondayDec 28, 2020 10:08 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures $12M in Registered Direct Offering

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced the closing of its registered direct offering of 3,116,884 shares of its common stock with a single health care-dedicated institutional investor. Genprex secured gross proceeds of $12 million, before deducting commissions and estimated expenses, with the offering priced at-the-market under Nasdaq rules at a price of $3.85 per share. “We believe that the closing of this transaction with a single, health care-dedicated institutional investor is further evidence that the potential of our gene therapies for cancer and diabetes is gaining recognition within the community…

MondayDec 28, 2020 9:38 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Featured in Equity Research Report

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in an equity research report by Maxim Group LLC. The piece discusses VistaGen’s strongest positioning yet, based on its pharmaceutical pipeline coupled with financing and a rising mental health pace. The report reads, “On 12/18, VistaGen announced pricing of an equity financing, raising gross proceeds of $100M (~$93M net) and bringing the company's cash balance to ~$103M. Importantly, the financing included participation of some leading institutional health care investors, which in our view is further validation of VistaGen's…

WednesdayDec 23, 2020 2:43 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Integrates Data, AI to Pave Path for Better Health Outcomes

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, is positioned to play a critical role in the precision oncology industry. The company integrates AI technology with oncologists’ clinical decision-making processes, paving the way for improved health outcomes. A recent article discussing this reads, “POAI is focused on the use of data and artificial intelligence to develop personalized cancer therapies through its trove of valuable assets, including a database of clinically validated historical and outcome data from patient tumors, an in-house Clinical Laboratory Improvement Amendments (‘CLIA’)-certified…

WednesdayDec 23, 2020 2:32 pm

QualityStocksNewsBreaks – Sustainable Green Team Ltd. (SGTM) Initiates Strategic Engagement to Transpire Vision, Achieve NASDAQ Uplisting

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently engaged Anthony L.G. PLLC to initiate the FORM-10 process to become fully reporting, assist with all SEC legal matters and uplist to the NASDAQ. The company initiated the engagement following a highly successful year marked by a string of lucrative contracts that included agreements with The Kroger Co., Circle K, 7-Eleven, Menards Inc., Old Castle Lawn & Garden, and more. “We have communicated with many firms since our audit completion to see who would be best suited for our team, shareholders,…

WednesdayDec 23, 2020 2:20 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Elevates Artists to Virtual Stage

Friendable (OTC: FDBL), a mobile technology and marketing company that leverages proprietary applications to connect and engage users, creates new revenue streams for artists. In an era of lockdowns and social distancing, Friendable’s platform, Fan Pass, rises above current challenges to shine the spotlight on artists via a virtual stage and provide craved connections. A recent article discussing this reads, “The live-streaming platform Fan Pass is FDBL’s flagship offering designed to help artists engage with their fans around the world and earn revenue from live-streaming performances, merchandise sales and fan subscriptions. The Fan Pass platform supports artists at all levels,…

Site Search

Company Search

Category: QualityStocksNewsBreaks